Download presentation
Presentation is loading. Please wait.
1
Basic Dysrhythmia &Recording ECG
Kamlya balgoon 2009
2
ECG - Analysis Use a consistent method to analyze an ECG Rate Rhythm
Assess P wave Assess P wave to QRS ratio 1=1 Interval duration Identify abnormalities kemo 2009
3
Lets Have A Deal …!!!! Normal P, normal P-R, normal QRS, normal P:QRS ratio = Sinus …… Problem in the P wave = Atrial ……… Problem in the QRS = Ventricular ……… More P waves than QRS = 2nd or 3rd Degree AV Block. Fibrillation = always irregular kemo 2009
4
Dysrhythmia !!! Abnormal conduction of electrical through the heart.
It causes disturbance heart rate , heart rhythm It named according to site of origin of impulse & conduction kemo 2009
5
Arrhythmias Originates from the SA node = Sinus
Originates from the atria = atrial Originates from the AV node = nodal or Junctional Originates from the ventricles ( high ) = Idioventricular Originates from the ventricles (myocardial tissue ) = Ventricular Impulse delay in the AV node = Block No impulse = Asystole kemo 2009
6
Sinus Arrhythmias 1- Sinus Rhythm ( the only normal one ) Regular
P-R interval Normal Normal identical P waves Each P followed by a QRS Normal QRS Rate bpm Normal QRS PR interval kemo 2009
7
2-Sinus Tachycardia Ventricle & a trial rate ; greater than 100
Ventricle & a trial rhythm : Regular QRS shape & duration : normal P wave shape normal P-R interval normal between 0,12 & o,20 second Normal identical P waves Each P followed by a QRS P: QRS ratio : 1:1 kemo 2009
8
2-Sinus Tachycardia kemo 2009
9
2-Sinus Tachycardia Causes Treatment
Normal physiologic with increase cardiac out put Shock exercise anxiety fever Anemia Medication sympathomimetic & parasympatholytic (atropine ,epinephrine ) Treatment Treat cause Medication ( antipyretics , beta blockers ) kemo 2009
10
3- Sinus Bradycardia Ventricle & a trial rate : less than 60
Ventricle & a trial rhythm : Regular QRS shape & duration : Normal P wave shape Normal P-R interval Normal between 0,12 & o,20 second Normal identical P waves Each P followed by a QRS P: QRS ratio : 1:1 kemo 2009
11
3- Sinus Bradycardia kemo 2009
12
3- Sinus Bradycardia Causes Treatment Slower metabolic need
( Sleep , Hypothermia , hypothyroidism ) Vagal stimulation ( vomiting , suction , sever pain ) Medication ( beta blockers , calcium channel blockers ) Eye surgery Increase intracranial pressure Treatment Treat causes Medication ( atropine ,epinephrine ) kemo 2009
13
4- Sinus arrhythmia or sinus block
Same as sinus but with a missed beat. After missing a beat, the rhythm will continue in regularity. A total beat missed kemo 2009
14
Sinus arrhythmia P-R interval Normal Normal identical P waves
It occurs impulse irregular rhythm Rate increase with inspiration & decrease with expiration It include heart disease ( valvular disease ) P-R interval Normal Normal identical P waves Each P followed by a QRS Normal QRS Rate bpm kemo 2009
15
Atrial Arrhythmias General Characteristics P wave Abnormal
Multiple Foci Regular or Irregular Fast most of the time Normal QRS always kemo 2009
16
A trial dysrhythmias Premature a trial complex A trial Fibrillation
A trial Flutter Atrial Tachycardia kemo 2009
17
A trial dysrhythmias 1- Premature a trial complex Causes Treatment
An electrical impulse starts in atrium before next normal impulse of SA node Causes Caffeine , alcohol , nicotine Treatment Treat causes kemo 2009
18
Premature A trial Complex ( PAC)
Ventricle & a trial rate depend on underlying rhythm Ventricle & a trial rhythm : irregular ( due to early p wave creating a PP interval is shorter QRS shape & duration : normal P wave shape an early & different p wave , hidden in T wave P-R interval Normal between 0,12 & o,20 second Each P followed by a QRS P: QRS ratio : 1:1 kemo 2009
19
Premature A trial Complex ( PAC)
kemo 2009
20
Unequal R-R = irregular
2- A trial Fibrillation Atrial fibrillation causes rapid ,disorganized & of artial muscle Unequal R-R = irregular kemo 2009
21
1- Atrial Fibrillation Causes Heart failure ,
A rtial enlargement, hypertension , Treatment Digoxin , Beta blockers ( Diogxin ) Anticoagulant if rhythm present for greater 48 hours Synchronized cardio version if rhythm present less for 48 hours kemo 2009
22
Atrial Fibrillation Ventricle & a trial rate : a trial rate 300 – 600
Ventricle rate 120 to 200 in untreated a trial fibrillation Ventricle & a trial rhythm : highly irregular QRS shape & duration : normal P wave shape : no discernible p wave , irregular undulating wave are seen are termed fibrillatory or f waves P-R interval not can measure Each P followed by a QRS P: QRS ratio : many :1 kemo 2009
23
Unequal R-R = irregular
Atrial Fibrillation Unequal R-R = irregular kemo 2009
24
3- A trial Flutter ٍ Normal QRS F wave kemo 2009
25
2- Atrial Flutter Causes Treatment
Heart disease ( valvular disorder , Rheumatic & ischemic heart disease ) Treatment Adenocard Diltazem kemo 2009
26
Atrial Flutter It occur in atrium & creates impulses at an artial rate 250 to 400 times per minute It cause serious signs ( chest pain .shortness breathing ,low blood pressure ) Treatment Electrical Cardiovesion kemo 2009
27
Atrial Flutter Ventricle & a trial rate : a trial rate 250 – 400
Ventricle rate 75to 150 in untreated a trial fibrillation Ventricle & a trial rhythm : Mostly regular, but it can be irregular QRS shape & duration : normal P wave shape : saw –toothed shape this waves are referred to as F wave P-R interval : multiple F wave Each P followed by a QRS P: QRS ratio : 2 :1 , 3 :1, 4 :1 kemo 2009
28
4- Atrial Tachycardia Some times it is called Supraventricular Tachycardia ( SVT ). Very fast rate > 150 bpm. Normal QRS. No P wave .or very difficult discern No P wave Normal QRS Very fast kemo 2009
29
4- Atrial Tachycardia Some times it is called Supraventricular Tachycardia ( SVT ). Very fast rate > 150 bpm. Normal QRS. No P wave. No P wave Normal QRS Very fast kemo 2009
30
4- Atrial Tachycardia Cases Treatment Ischemia Hypoxia Heart failure
Adenocard Diltazem Synchronized cardioversion kemo 2009
31
Thank you kamlya kemo 2009
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.